TrialPeerJ2022

Development and validation of a multi-parameter nomogram for predicting prostate cancer: a retrospective analysis from Handan Central Hospital in China.

Libin Nan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.